alexa

Search in Indianmoney's WealthPedia

 
Home News Indoco gets USFDA nod for Febuxostat tablets

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Medical LoanClick Here
 
 
Indoco gets USFDA nod for Febuxostat tablets

Indoco gets USFDA nod for Febuxostat tablets

Tuesday, December 31, 2019, 8:02 PM

Indoco Remedies said it has got final approval from the US health-regulator for Febuxostat-tablets used for the treatment of gout caused by excessive levels of uric acid in the blood. The market size of Febuxostat tablets in the US is over USD 500-million (around Rs.3,565-crore). Febuxostat is used for the treatment of gout caused by excessive levels of uric acid in the blood (hyperuricemia).
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

What is your Credit Score? Get FREE Credit Score in 1 Minute!

Get Start Now!
CIBIL Meter
Get It now!
Attention!

This is to inform that Suvision Holdings Pvt Ltd ("IndianMoney.com") do not charge any fees/security deposit/advances towards outsourcing any of its activities. All stake holders are cautioned against any such fraud.